01 6Tremfya
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 1,347
2019 Revenue in Millions : 1,012
Growth (%) : 33
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 2,127
2020 Revenue in Millions : 1,347
Growth (%) : 58
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 2,668
2021 Revenue in Millions : 2,127
Growth (%) : 25
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 3,147
2022 Revenue in Millions : 2,668
Growth (%) : 18
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2018 Revenue in Millions : 544
2017 Revenue in Millions : 63
Growth (%) : 763%
Main Therapeutic Indication : Immunology
Currency : USD
2019 Revenue in Millions : 1,012
2018 Revenue in Millions : 544
Growth (%) : 86
LOOKING FOR A SUPPLIER?
